Arthur Herbst to United States
This is a "connection" page, showing publications Arthur Herbst has written about United States.
Connection Strength
0.297
-
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
Score: 0.059
-
Adjusting to the present: presidential address. Am J Obstet Gynecol. 1999 Apr; 180(4):779-83.
Score: 0.017
-
Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.
Score: 0.016
-
Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2015 Apr; 24(4):308-15.
Score: 0.013
-
DES exposure: an update. Contemp Pediatr. 1994 Nov; 11(11):59-62, 64, 66 passim.
Score: 0.012
-
The Bethesda system for cervical/vaginal cytologic diagnoses. Clin Obstet Gynecol. 1992 Mar; 35(1):22-7.
Score: 0.010
-
Mammography screening behaviors of women exposed prenatally to diethylstilbestrol. J Womens Health (Larchmt). 2012 Feb; 21(2):209-14.
Score: 0.010
-
Robert E. Scully, MD: a clinician's perspective. Hum Pathol. 1991 Aug; 22(8):749.
Score: 0.010
-
Concerns regarding the Bethesda System. Int J Gynecol Pathol. 1991; 10(4):326-8.
Score: 0.009
-
The Bethesda System for cervical/vaginal cytologic diagnoses: a note of caution. Obstet Gynecol. 1990 Sep; 76(3 Pt 1):449-50.
Score: 0.009
-
Medical professional liability and obstetric care: the Institute of Medicine report and recommendations. Obstet Gynecol. 1990 Apr; 75(4):705-9.
Score: 0.009
-
Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6(6):343-6.
Score: 0.009
-
Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health. 2009 Aug 18; 8:37.
Score: 0.009
-
Breast cancer screening in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2009 Apr; 18(4):547-52.
Score: 0.008
-
Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology. 2008 Mar; 19(2):251-7.
Score: 0.008
-
Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer. 2007 Jul 15; 121(2):356-60.
Score: 0.007
-
Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26; 316(9):514-6.
Score: 0.007
-
The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
Score: 0.007
-
Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 2006 Oct 01; 164(7):682-8.
Score: 0.007
-
Mortality in women given diethylstilbestrol during pregnancy. Br J Cancer. 2006 Jul 03; 95(1):107-11.
Score: 0.007
-
Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology. 2005 Jul; 16(4):583-6.
Score: 0.006
-
Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001 Nov; 12(9):837-45.
Score: 0.005
-
Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001 Aug 15; 154(4):316-21.
Score: 0.005
-
Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001 Apr 04; 93(7):545-51.
Score: 0.005
-
Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979 Dec 01; 135(7):876-86.
Score: 0.004
-
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977 May 01; 128(1):43-50.
Score: 0.004
-
Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr; 39(4 Suppl):1892-5.
Score: 0.004
-
Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
Score: 0.003
-
Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
Score: 0.003
-
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994 Jun 15; 271(23):1866-9.
Score: 0.003
-
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
Score: 0.003
-
Stilbestrol-adenosis-carcinoma syndrome: geographic distribution. N Engl J Med. 1971 Sep 16; 285(12):691.
Score: 0.002
-
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 04 22; 284(15):878-81.
Score: 0.002
-
Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol. 1978 Apr; 51(4):453-8.
Score: 0.001
-
Registry of clear-cell carcinoma of genital tract in young women. N Engl J Med. 1971 Aug 12; 285(7):407.
Score: 0.001